← Leaderboards
Michael Billard
Adaptive Phage Therapeutics, Inc.
$296,787
Attributed
$296,787
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$296,787 · 1
By mechanism
N43$296,787 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antimicrobial Resistance”
- Urs Ochsner · Crestone, Inc.$23,443,941
- Ryan Cirz · Revagenix, Inc.$11,270,810
- Keith Kaye · University Of Michigan At Ann Arbor$11,130,173
- Nadine Georges Rouphael · Emory University$10,951,555
- Bruce Blough · Research Triangle Institute$8,948,381
- Sujatha Rashid · American Type Culture Collection$7,500,000
Research focus
Antimicrobial ResistanceBacteriophagesGram-Negative BacteriaSmall Business Innovation Research GrantTherapeutic Development